In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease

Abstract

This study provides Class III evidence that total CSF α-synuclein does not accurately distinguish patients with PD from HCs, and that monoclonal antibody staining for SMG and skin total α-synuclein is specific but not sensitive for PD diagnosis.